仅对制药厂、医药研发公司、医药研究所、医院提供信息服务,不对个人提供信息服务!

类别

搜索

地點

訂閱此搜索

9.42 Euro €

药品编号 06697999 持证商 SCHAPER & BRÜMMER GmbH & Co. KG 包装规格 100 St Packungsnorm N3 产品名 Esberitox Tabletten 剂型 Tabletten Pfl. Arzneimittel ja 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/esberitox-tabletten-100-st-06697999.html

· 十一月 20, 2018
66.62 Dollar US$

药品名:Promethazine 50mg/ml 1ml SDA - Box/25生产商:WEST-WARDProduct Code: CP-07-0149635NDC Code: 0641-1496-35

· 十二月 13, 2018
了解卖家

New Drug Application (NDA): 211230Company: JAZZTreatment for: Narcolepsy, Obstructive Sleep Apnea/Hypopnea SyndromeDate of Approval:03/20/2019DrugName:SUNOSIActive Ingredients:SOLRIAMFETOL HYDROCHLORIDEStrength:EQ 150MG BASEPackage:30 BottlesDosage Form:TABLETDosage Route:ORALTE Code:...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 211230Company: JAZZTreatment for: Narcolepsy, Obstructive Sleep Apnea/Hypopnea SyndromeDate of Approval:03/20/2019DrugName:SUNOSIActive Ingredients:SOLRIAMFETOL HYDROCHLORIDEStrength:EQ 75MG BASEPackage:100 BottlesDosage Form:TABLETDosage Route:ORALTE Code:...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 211230Company: JAZZTreatment for: Narcolepsy, Obstructive Sleep Apnea/Hypopnea SyndromeDate of Approval:03/20/2019DrugName:SUNOSIActive Ingredients:SOLRIAMFETOL HYDROCHLORIDEStrength:EQ 75MG BASEPackage:30 BottlesDosage Form:TABLETDosage Route:ORALTE Code:N...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 211371Company: SAGE THERAPTreatment for: Postpartum DepressionDate of Approval:03/19/2019DrugName:ZULRESSOActive Ingredients:BREXANOLONEStrength:100MG/20ML (5MG/ML)Dosage Form:SOLUTIONDosage Route:INTRAVENOUSTE Code:NoneRLD:YesRS:YesNDC:72152-547-20Start Ma...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 208259Company: AERIE PHARMS INCTreatment for: Glaucoma (Open Angle), Intraocular HypertensionDate of Approval:03/12/2019DrugName:ROCKLATANActive Ingredients:LATANOPROST; NETARSUDIL DIMESYLATEStrength:0.005%;EQ 0.02% BASEDosage Form:SOLUTION/DROPSDosage Rout...

· 五月 11, 2020
了解卖家

Biologic License Application (BLA): 761081Company: PFIZER INCTreatment for: Breast Cancer, Gastric CancerDate of Approval:03/11/2019DrugName:TRAZIMERAActive Ingredients:TRASTUZUMAB-QYYPStrength:420MGDosage Form:INJECTABLEDosage Route:INJECTIONTE Code:NoneRLD:NoRS:NoNDC:0069-0305-01Start Ma...

· 五月 11, 2020
了解卖家

New Drug Application (NDA): 211243Company: JANSSEN PHARMSTreatment for: Treatment-Resistant DepressionDate of Approval:03/05/2019DrugName:SPRAVATOActive Ingredients:ESKETAMINE HYDROCHLORIDEStrength:EQ 28MG BASE  84mgDosage Form:SPRAYDosage Route:NASALTE Code:NoneRLD:YesRS:YesNDC:...

· 五月 11, 2020
了解卖家

New Drug Application (NDA): 211243Company: JANSSEN PHARMSTreatment for: Treatment-Resistant DepressionDate of Approval:03/05/2019DrugName:SPRAVATOActive Ingredients:ESKETAMINE HYDROCHLORIDEStrength:EQ 28MG BASE  56mgDosage Form:SPRAYDosage Route:NASALTE Code:NoneRLD:YesRS:YesNDC:...

· 五月 11, 2020
了解卖家

New Drug Application (NDA): 212038Company: PURDUE PHARMA LPTreatment for: Attention-Deficit / Hyperactivity DisorderDate of Approval:02/27/2019DrugName:ADHANSIA XRActive Ingredients:METHYLPHENIDATE HYDROCHLORIDEStrength:85MGDosage Form:CAPSULE, EXTENDED RELEASEDosage Route:ORALTE Code...

· 五月 11, 2020
了解卖家

New Drug Application (NDA): 212038Company: PURDUE PHARMA LPTreatment for: Attention-Deficit / Hyperactivity DisorderDate of Approval:02/27/2019DrugName:ADHANSIA XRActive Ingredients:METHYLPHENIDATE HYDROCHLORIDEStrength:70MGDosage Form:CAPSULE, EXTENDED RELEASEDosage Route:ORALTE Code...

· 五月 11, 2020
Top